A new research paper titled "Gene expression signatures of human senescent corneal and conjunctival epithelial cells" has been published in Aging. In this new study, researchers Koji Kitazawa, Akifumi ...

Please provide your email address to receive an email when new articles are posted on . The nonprofit eye bank Eversight has partnered with Emmecell, a clinical-stage biotechnology company, to advance ...

Sight-robbing injuries to the cornea can be repaired using a groundbreaking experimental stem cell treatment, a new study shows. The cornea -- the clear outermost layer of the eye -- can become ...

Researchers headed by a team at Mass Eye and Ear, Harvard Medical School, reported positive data from a Phase I clinical study evaluating a stem cell treatment known as cultivated autologous limbal ...

This study identifies mechanisms of epithelial growth post-SMILE surgery and suggests preventive and treatment measures, including subflap debris removal, to address corneal epithelial ingrowth.

In a pioneering study, stem-cell-derived corneal implants improve sight for patients with severe vision impairment, offering a potential breakthrough for treating limbal stem cell deficiency.

The first-ever corneal stem-cell transplants in the U.S. proved feasible and safe, allowed patients to receive new corneas, and in some cases improved vision as a solo procedure, a small preliminary ...

CALEC could become one of the first major examples of stem cell therapy's potential to repair once-unfixable injuries. Reading time 3 minutes Scientists at Mass Eye and Ear are winners of the 2025 ...

The procedure is used to treat limbal stem cell deficiency (LSCD). The limbus is the part of the eye where the cornea joins the sclera, and where the conjunctiva, which covers the sclera, ends.

“[...] our results from the RNA-Seq experiments show that senescent ocular surface cells, particularly SCj, have abnormal keratin expression patterns ...